News
0
The last week has seen its fair share of COVID-19 vaccine developments; Bharat Biotech’s candidate was found to be 81% effective, while a UK study...
0
Roche’s Actemra/RoActemra therapy, intended for slowing the rate of decline in pulmonary function for adults with systemic sclerosis-associated...
0
Amgen has announced it will acquire Five Prime Therapeutics for $38.00 per share in cash, representing an equity value of approximately $1.9...
0
CureVac and Novartis have signed an initial agreement for the manufacturing of CureVac’s COVID-19 vaccine candidate, CVnCoV.
Features
Early and managed access programmes provide opportunities for patients to get the treatments they need faster - but the COVID-19 pandemic has...
Featured Appointment
Verona Pharma has appointed Lisa Deschamps, Senior Vice President and Chief Business Officer of Novartis Gene Therapies, as Non-Executive Director...
Service Company News
Featured Event
11/01/2021 - 15/01/2021 -
Virtual Event,
@Pharmafocus
